What are the characteristic ECG findings of Yamaguchi syndrome (apical hypertrophic cardiomyopathy) and how should they be interpreted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yamaguchi Syndrome ECG Findings

Yamaguchi syndrome (apical hypertrophic cardiomyopathy) is characterized by giant negative T-wave inversions (>10 mm) in the precordial leads V3-V6, particularly V4, along with increased R-wave amplitude following the pattern RV4 ≥ RV5 > RV3 1.

Characteristic ECG Features

Primary Diagnostic Markers

  • Giant T-wave inversions: Deep symmetric negative T-waves exceeding 10 mm in depth, most prominent in leads V4-V6 2, 3, 4
  • Increased R-wave amplitude: The distinctive pattern shows RV4 ≥ RV5 > RV3, which is a critical diagnostic sign 5
  • Voltage criteria: Sum of RV5 + SV1 typically exceeds 35 mm 2

Additional ECG Abnormalities

The ECG demonstrates truly giant QRS complexes in precordial leads, particularly V4, with rightward superior and posterior shift of the T-wave vector 6. These changes are present in 75-95% of patients with apical HCM and may appear before wall thickening is evident on echocardiography 7.

Clinical Interpretation Pitfalls

Critical caveat: These ECG findings frequently mimic acute coronary syndrome, leading to unnecessary invasive procedures 3, 4, 8. The combination of chest pain with giant T-wave inversions can create a Wellens-like pattern that suggests critical LAD disease when none exists 8.

Key Distinguishing Features

  • Serial troponins remain normal despite dramatic ECG changes 3
  • ECG abnormalities do not correlate with severity or pattern of hypertrophy on imaging 7
  • The specific R-wave progression pattern (RV4 ≥ RV5 > RV3) is more specific for apical HCM than for ischemia 5

Diagnostic Algorithm

When encountering giant precordial T-wave inversions:

  1. Assess R-wave pattern: Look specifically for RV4 ≥ RV5 > RV3 progression
  2. Measure T-wave depth: Giant inversions (>10 mm) in V4-V6 strongly suggest apical HCM
  3. Check troponins: Normal serial troponins despite dramatic ECG changes favor apical HCM over ACS
  4. Proceed to imaging: Echocardiography will show apical wall thickness >15 mm (or ≥13 mm with family history or pathogenic variant) with the characteristic "ace of spades" configuration 1
  5. Consider CMR: When echocardiography is inconclusive, cardiac MRI definitively demonstrates apical hypertrophy and quantifies fibrosis 9, 10, 3

Diagnostic Criteria Context

In adults, apical HCM is diagnosed when apical wall thickness is <15 mm but the apex:base wall thickness ratio exceeds 1.0, accompanied by the characteristic marked T-wave inversions in precordial leads 1. This represents relative hypertrophy rather than absolute wall thickness criteria.

The 2024 Canadian guidelines specifically note that apical HCM can be diagnosed with wall thickness of 13-14 mm in the absence of family history or genetic variants when the characteristic ECG pattern and relative apical hypertrophy are present 1.

Monitoring Recommendations

  • Initial evaluation: 12-lead ECG is mandatory 7, 11
  • Follow-up: Annual ECGs are reasonable for clinically stable patients 7
  • Holter monitoring: 24-48 hour monitoring every 1-2 years to assess for ventricular arrhythmias and sudden cardiac death risk 7, 11

The ECG abnormalities in Yamaguchi syndrome are highly characteristic but non-specific for disease severity, making multimodal imaging essential for complete evaluation and risk stratification 1.

References

Research

[Apical hypertrophic cardiomyopathy].

Archives des maladies du coeur et des vaisseaux, 1996

Research

Electrocardiogram in apical hypertrophic cardiomyopathy with a speculation as to the mechanism of its features.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.